Market Overview:
The global nanomaterials in personalized medicine market is expected to grow at a CAGR of XX% during the forecast period from 2018 to 2030. The growth of this market can be attributed to the increasing demand for targeted and individualized therapies, rising prevalence of chronic diseases, and growing investments in R&D activities. The global nanomaterials in personalized medicine market is segmented on the basis of type, application, and region. On the basis of type, the market is segmented into nano-medicine, nanometer medical instrumentation, and others. The nano-medicine segment is further sub-segmented into drug delivery systems (DDS), diagnostics & therapeutics products (DTx), implantable devices & sensors (IDS), tissue engineering scaffolds (TES) & regenerative medicines (RM), medical textiles/clothing/bandages (MTCB), wound dressings & adhesive bandages (WDAB). The drug delivery systems segment accounted for a major share of the global nano-medicine market in 2017 owing to its wide range of applications across various therapeutic areas such as oncology, CNS products,, anti-infection agents etc. On the basis if application;the anticancer drugs are expected to witness high growth during th eforecast period due t o their increasing adoption for treatment o fvarious types oftumors .
Product Definition:
Nanomaterials are materials with at least one dimension sized from 1 to 100 nanometers. Nanomaterials have unique optical, electronic, and mechanical properties that can be exploited in a variety of applications including medicine. For example, nanoparticles can be used to deliver drugs or genes directly to specific cells in the body, improving the efficacy of treatments. Additionally, nanoparticles can be used as sensors to detect disease biomarkers or track the progress of a treatment. Nanomaterials offer great potential for use in personalized medicine and their impact on this field is only beginning to be realized.
Nano-Medicine:
Nano-medicine is the new field of science that studies the use of nanomaterials in medicine. It has been observed that nanoparticles (NPs) have a wide range of applications in medical treatment. Some common NP-based products include drug delivery systems, diagnostic & imaging agents, and therapeutic agents.
Nanometer Medical Instrument:
Nanometer medical instrument is a billionth of a meter and used for measuring nanomaterials in personalized medicine. Nanometer medical instrument can measure the size of molecules, proteins, DNA & RNA. Nanometers are used to measure the size of biomolecules because they have unique properties such as high surface area to volume ratio which makes them easier to detect and identify small biological molecules.
Application Insights:
The application segment is divided into anticancer, CNS products, anti-infection, others and includes other applications such as optoelectronics and sensors. Nanomaterials in cancer treatment include nanoshells, nanocarriers and their combinations that enhance the efficacy of chemotherapy drugs by enhancing the drug delivery to tumor cells.
Nanotechnology in antimicrobial agents finds wide applications including novel antibacterial materials for toothpaste & washcloths that are free from any harmful chemicals to protect against infections caused by bacteria or germs. The rising need for new antibiotics has led researchers to develop a number of novel antimicrobial agents based on engineered nanoparticles which have shown promising results against several bacterial strains.
Nanoparticle-based therapeutics open up new possibilities in drug delivery systems due to their unique ability to penetrate cell membranes.
Regional Analysis:
North America dominated the global market in 2017. This is due to the presence of a large number of nanotechnology-based research organizations and universities in this region. Moreover, increasing investments by private entities for developing novel therapeutics based on nanomaterials are expected to boost growth over the forecast period.
Asia Pacific is anticipated to witness lucrative growth over the forecast period owing to rising healthcare expenditure, growing population, and improving economic conditions in emerging countries such as China and India.
Growth Factors:
- Increasing demand for nanomaterials in the field of personalized medicine from various end-use industries such as pharmaceuticals, medical devices, and diagnostics.
- Rising prevalence of chronic diseases and increasing geriatric population are the key factors driving the growth of nanomaterials in personalized medicine market.
- Growing investments by government bodies and private players for research and development activities in nanotechnology is another major factor propelling the growth of this market during the forecast period.
- Technological advancements in nanoparticle synthesis techniques that offer better performance, quality, and purity are expected to fuel the demand for nanomaterials during the forecast period.
Scope Of The Report
Report Attributes
Report Details
Report Title
Nanomaterials in Personalized Medicine Market Research Report
By Type
Nano-Medicine, Nanometer Medical Instrument, Others
By Application
Anticancer, CNS Products, Anti-infection, Others
By Companies
Abbott, Amgen, Biogen, Celgene, Gilead Sciences, Merck and Co, Pfizer, Roche, Sanofi, Stryker, Teva Pharmaceuticals
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
182
Number of Tables & Figures
128
Customization Available
Yes, the report can be customized as per your need.
Global Nanomaterials in Personalized Medicine Market Report Segments:
The global Nanomaterials in Personalized Medicine market is segmented on the basis of:
Types
Nano-Medicine, Nanometer Medical Instrument, Others
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Anticancer, CNS Products, Anti-infection, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Abbott
- Amgen
- Biogen
- Celgene
- Gilead Sciences
- Merck and Co
- Pfizer
- Roche
- Sanofi
- Stryker
- Teva Pharmaceuticals
Highlights of The Nanomaterials in Personalized Medicine Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Nano-Medicine
- Nanometer Medical Instrument
- Others
- By Application:
- Anticancer
- CNS Products
- Anti-infection
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Nanomaterials in Personalized Medicine Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Nanomaterials are materials with dimensions of one billionth of a meter or less. Nanomaterials can be used in personalized medicine to target and treat specific diseases.
Some of the key players operating in the nanomaterials in personalized medicine market are Abbott, Amgen, Biogen, Celgene, Gilead Sciences, Merck and Co, Pfizer, Roche, Sanofi, Stryker, Teva Pharmaceuticals.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Nanomaterials in Personalized Medicine Market Overview 4.1 Introduction 4.1.1 Market Taxonomy 4.1.2 Market Definition 4.1.3 Macro-Economic Factors Impacting the Market Growth 4.2 Nanomaterials in Personalized Medicine Market Dynamics 4.2.1 Market Drivers 4.2.2 Market Restraints 4.2.3 Market Opportunity 4.3 Nanomaterials in Personalized Medicine Market - Supply Chain Analysis 4.3.1 List of Key Suppliers 4.3.2 List of Key Distributors 4.3.3 List of Key Consumers 4.4 Key Forces Shaping the Nanomaterials in Personalized Medicine Market 4.4.1 Bargaining Power of Suppliers 4.4.2 Bargaining Power of Buyers 4.4.3 Threat of Substitution 4.4.4 Threat of New Entrants 4.4.5 Competitive Rivalry 4.5 Global Nanomaterials in Personalized Medicine Market Size & Forecast, 2018-2028 4.5.1 Nanomaterials in Personalized Medicine Market Size and Y-o-Y Growth 4.5.2 Nanomaterials in Personalized Medicine Market Absolute $ Opportunity
Chapter 5 Global Nanomaterials in Personalized Medicine Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Nanomaterials in Personalized Medicine Market Size Forecast by Type
5.2.1 Nano-Medicine
5.2.2 Nanometer Medical Instrument
5.2.3 Others
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Nanomaterials in Personalized Medicine Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Nanomaterials in Personalized Medicine Market Size Forecast by Applications
6.2.1 Anticancer
6.2.2 CNS Products
6.2.3 Anti-infection
6.2.4 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Nanomaterials in Personalized Medicine Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Nanomaterials in Personalized Medicine Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Nanomaterials in Personalized Medicine Analysis and Forecast
9.1 Introduction
9.2 North America Nanomaterials in Personalized Medicine Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Nanomaterials in Personalized Medicine Market Size Forecast by Type
9.6.1 Nano-Medicine
9.6.2 Nanometer Medical Instrument
9.6.3 Others
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Nanomaterials in Personalized Medicine Market Size Forecast by Applications
9.10.1 Anticancer
9.10.2 CNS Products
9.10.3 Anti-infection
9.10.4 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Nanomaterials in Personalized Medicine Analysis and Forecast
10.1 Introduction
10.2 Europe Nanomaterials in Personalized Medicine Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Nanomaterials in Personalized Medicine Market Size Forecast by Type
10.6.1 Nano-Medicine
10.6.2 Nanometer Medical Instrument
10.6.3 Others
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Nanomaterials in Personalized Medicine Market Size Forecast by Applications
10.10.1 Anticancer
10.10.2 CNS Products
10.10.3 Anti-infection
10.10.4 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Nanomaterials in Personalized Medicine Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Nanomaterials in Personalized Medicine Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Nanomaterials in Personalized Medicine Market Size Forecast by Type
11.6.1 Nano-Medicine
11.6.2 Nanometer Medical Instrument
11.6.3 Others
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Nanomaterials in Personalized Medicine Market Size Forecast by Applications
11.10.1 Anticancer
11.10.2 CNS Products
11.10.3 Anti-infection
11.10.4 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Nanomaterials in Personalized Medicine Analysis and Forecast
12.1 Introduction
12.2 Latin America Nanomaterials in Personalized Medicine Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Nanomaterials in Personalized Medicine Market Size Forecast by Type
12.6.1 Nano-Medicine
12.6.2 Nanometer Medical Instrument
12.6.3 Others
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Nanomaterials in Personalized Medicine Market Size Forecast by Applications
12.10.1 Anticancer
12.10.2 CNS Products
12.10.3 Anti-infection
12.10.4 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Nanomaterials in Personalized Medicine Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Nanomaterials in Personalized Medicine Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Nanomaterials in Personalized Medicine Market Size Forecast by Type
13.6.1 Nano-Medicine
13.6.2 Nanometer Medical Instrument
13.6.3 Others
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Nanomaterials in Personalized Medicine Market Size Forecast by Applications
13.10.1 Anticancer
13.10.2 CNS Products
13.10.3 Anti-infection
13.10.4 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Nanomaterials in Personalized Medicine Market: Competitive Dashboard
14.2 Global Nanomaterials in Personalized Medicine Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Abbott
14.3.2 Amgen
14.3.3 Biogen
14.3.4 Celgene
14.3.5 Gilead Sciences
14.3.6 Merck and Co
14.3.7 Pfizer
14.3.8 Roche
14.3.9 Sanofi
14.3.10 Stryker
14.3.11 Teva Pharmaceuticals